Skip to main content

SYSTEMATIC REVIEW article

Front. Pain Res.
Sec. Pharmacological Treatment of Pain
Volume 5 - 2024 | doi: 10.3389/fpain.2024.1398442

Non-Opioid Psychiatric Medications for Chronic Pain: Systemic Review and Meta-Analysis

Provisionally accepted
  • 1 The Institute of Living, Hartford, Connecticut, United States
  • 2 University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
  • 3 UCONN Health, Farmington, Connecticut, United States
  • 4 CIMPAR S.C., Oak Park, Illinois, United States
  • 5 Boston Medical Center, Boston, Massachusetts, United States
  • 6 Connecticut Valley Hospital, Middletown, Connecticut, United States
  • 7 Liaquat College of Medicine and Dentistrty, Karachi, Sindh, Pakistan
  • 8 Oregon State Hospital, Salem, United States
  • 9 Larkin Community Hospital, South Miami, United States
  • 10 Maimonides Medical Center, Brooklyn, United States
  • 11 University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States
  • 12 Bogomolets National Medical University, Kyiv, Ukraine
  • 13 Dhaka Medical College and Hospital, Dhaka, Dhaka, Bangladesh
  • 14 University of Arkansas, Fayetteville, North Carolina, United States
  • 15 Texas Tech University, Lubbock, Texas, United States
  • 16 Suburban Community Hospital, Norristown, Pennsylvania, United States
  • 17 Centre for Brain Research, Indian Institute of Science, Bangalore, Karnataka, India
  • 18 Directorate of Health Services Kashmir (DHSK), Srinagar, Jammu and Kashmir, India
  • 19 VA Greater Los Angeles Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Los Angeles, California, United States
  • 20 Department of Mental Health, ASL 4, Teramo, Italy
  • 21 Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States

The final, formatted version of the article will be published soon.

    1

    Keywords: Chronic pain & fibromyalgia, non opioid analgesics, Pain Management (MeSH), SNRI (serotonin-norepinephrine reuptake inhibitors), Tricyclic - antidepressant drug, Gabapentanoids, Back Pain, psychiatric medication use

    Received: 12 Mar 2024; Accepted: 09 Sep 2024.

    Copyright: © 2024 Ayub, MD, Bachu, Jain, Parnia, Bhivandkar, Kaur, Ahmed, Karlapati, Prasad, Kochhar, Ayisire, Mitra, Ghosh, Srinivas, Ashraf, Papudesi, malo, Shoib, Hsu, De Berardis and Ahmed, MD. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Lakshit Jain, UCONN Health, Farmington, 06030, Connecticut, United States
    Domenico De Berardis, Department of Mental Health, ASL 4, Teramo, Italy

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.